Trial intelligence / Profile preview

Nemonoxacin vs moxifloxacin for community-acquired pneumonia

CTR20130195Phase 2Active

Sponsor
Huayu (Wuxi) Pharmaceutical
Start
Aug 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
Countries
1
01

Overview

A Phase 2 trial of nemonoxacin in community-acquired pneumonia (CAP), sponsored by Huayu (Wuxi) Pharmaceutical. Started Aug 2014; status: active.

02

Drugs

nemonoxacin
03

Conditions

community-acquired pneumonia (CAP)

Beyond the preview

Go deeper on CTR20130195.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on CTR20130195.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call